Role of the p38 MAPK pathway in induction of iNOS expression in human leukocytes

被引:4
|
作者
Jablonska, Ewa [1 ]
Ratajczak, Wioletta [1 ]
Jablonski, Jakub [2 ]
机构
[1] Med Univ Bialystok, Dept Immunol, PL-15274 Bialystok, Poland
[2] Med Univ Bialystok, Dept Toxicol, PL-15274 Bialystok, Poland
来源
FOLIA BIOLOGICA-KRAKOW | 2008年 / 56卷 / 1-2期
关键词
neutrophils; peripheral blood mononuclear cells; nitric oxide; inducible synthase of nitric oxide; cGMP; rhIL-15; rhIL-18;
D O I
10.3409/fb56_1-2.83-89
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inducible nitric oxide synthase (iNOS) is one of the enzymes responsible for NO production in neutrophils (PMN) and in peripheral blood mononuclear cells (PBMC). Several studies have demonstrated that iNOS expression is controlled by a wide group of cytokines which achieve their biological effect through, among others, the activation of the p38 MAPK pathway. The aim of the present study was to define the participation of the p38 MAPK pathway in the induction of iNOS expression and NO production by PMN and PBMC of healthy persons after stimulation of rhIL-15 and rhIL-18. We also estimated the influence of rhIL-15 and rhIL-18 on cGMP production by both population cells and the production of superoxide anion radicals by neutrophils. The results show that rhIL-15 and rhIL-18 induced an increase in the expression of iNOS and phospho-p38 MAPK in PMN and PBMC. We also found that PMN and PBMC, stimulated by these cytokines, released larger amounts of NO and cGMP in comparison with non-stimulated cells. Additionally, PMN showed a more pronounced ability to produce superoxide anions. The results suggest that iNOS activation in neutrophils and in peripheral blood mononuclear cells stimulated with rhIL-15 and rhIL-18 may be achieved through the assistance of the p38 MAPK pathway.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 50 条
  • [21] Regulation of iNOS expression by the MAPK pathway in human melanoma
    Ellerhorst, JA
    Ekmekcioglu, S
    Johnson, MK
    Johnson, MM
    Grimm, EA
    FEBS JOURNAL, 2005, 272 : 122 - 122
  • [22] P38 MAPK signaling pathway is involved in butyrate induced VDR-expression
    Daniel, C
    Gaschott, T
    Schroeder, O
    Stein, J
    GASTROENTEROLOGY, 2004, 126 (04) : A395 - A395
  • [23] The role of p38 MAPK pathway in ischemia-reperfusion injury of isolated liver
    王雨
    田伏洲
    汤礼军
    石力
    张晓琼
    中华肝脏病杂志, 2003, (03) : 43 - 45
  • [24] Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway
    Chang, PC
    Chen, TH
    Chang, CJ
    Hou, CC
    Chan, P
    Lee, HM
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1664 - 1675
  • [25] Role of p38 MAPK Pathway in induction of NOS Expression in Neutrophils and Peripheral Blood Mononuclear Cells in Patients With Squamous Cell Carcinoma of the Oral Cavity
    Ratajczak-Wrona, Wioletta
    Jablonska, Ewa
    Marcinczyk, Magdalena
    Grabowska, Zyta
    Piotrowski, Leszek
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (11) : 2354 - 2363
  • [26] Pulmonary fibrosis: the diverse role of the p38 MAPK
    Keppler, S.
    Nemeth, J.
    Frick, M.
    ACTA PHYSIOLOGICA, 2022, 236 : 279 - 279
  • [27] INOS activity and the formation of peroxynitrite play a key role in amplifying NFκB transcritpional activity via the p38 mapk kinase pathway
    Bellmann, K.
    Cabana, R.
    Charbonneau, A.
    Marette, A.
    DIABETOLOGIA, 2012, 55 : S272 - S272
  • [28] The p38 MAPK pathway controls the relationship between growth and differentiation in human β-cells
    De La Tour, DD
    Woo, SJ
    Tyrberg, B
    Demeterco, C
    Levine, F
    DIABETES, 2001, 50 : A338 - A338
  • [29] The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy
    Wang, Shudong
    Ding, Lijuan
    Ji, Honglei
    Xu, Zheng
    Liu, Quan
    Zheng, Yang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)
  • [30] The p38 MAPK Inhibitors and Their Role in Inflammatory Diseases
    Machado, Thamires R.
    Machado, Thayna R.
    Pascutti, Pedro G.
    CHEMISTRYSELECT, 2021, 6 (23): : 5729 - 5742